In this episode we are joined by Suzanne Frank. We discuss Inavo120 (Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer) study. We discuss the relevance of the data and how it might change practice going forward. This study is available to read at https://www.nejm.org/doi/full/10.1056/NEJMoa2404625 and the update at https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.1003
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Let's Talk About SACT
Let's Talk About Melanoma Focus
Let's Talk About Menopause and Cancer
Let's Talk About The Immunotherapy Specialist Advisory Group
Let's Talk About The Cancer Research UK Consent Form Project
Get summaries like this every morning.
Free AI-powered recaps of Let's Talk About SACT and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.